Figure 7From: Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkinePDGFR-α, MRP-1, Bcl-2 and p170 levels by western blotting. Nos, noscapine; IM, imatinib mesylate; Nos+IM, noscapine with imatinib mesylate. Results are presented as mean (%) ± SEM. Mean values for each group were calculated as the ratio of the density of the sample band to that of the β-actin band in each lane and multipled with 100 and they are the mean of three different experiments.Back to article page